Experimental and Clinical Studies on the Antifibrinolytic and Presumed Antithrombotic Effect of a Kallikrein Inhibitor (Trasylol)
- 1 January 1967
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 1 (1), 11-18
- https://doi.org/10.3109/00365596709133518
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Inhibition of Fibrinolytic and Thromboplastic Activity by Trasylol®Scandinavian Journal of Haematology, 1966
- Fibrinolyse und Blutverlust nach Prostata-Operationen und deren Beeinflußbarkeit durch AntifibrinolytikaDeutsche Medizinische Wochenschrift (1946), 1966
- Experimental and Clinical Studies on AMCA, the Antifibrinolytically Active Isomer of p‐Aminomethyl Cyclohexane Carboxylic AcidScandinavian Journal of Haematology, 1965
- Demonstration of Fibrinolytic Split Products in Human Serum by an Immunological Method in Spontaneous and Induced Fibrinolytic StatesScandinavian Journal of Haematology, 1964
- Über die Wirkung von Proteinaseinhibitor-Präparaten (Leberund Parotisinhibitor) auf die extravasale Fibrinolyse, Fibrinogenolyse und Blutgerinnungskonstanten im MenschenblutBlut: Zeitschrift für die Gesamte Blutforschung, 1963
- A Method for Determining Serum Inhibitors of Plasminogen ActivationScandinavian Journal of Clinical and Laboratory Investigation, 1962
- Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic SystemActa Medica Scandinavica, 1961
- Haemophilia in SwedenActa Medica Scandinavica, 1961
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957
- The Separation of the Antibodies, Isoagglutinins, Prothrombin, Plasminogen and β1-Lipoprotein into Subfractions of Human PlasmaJournal of the American Chemical Society, 1949